Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Anita A. Joshi"'
Autor:
Vesselina Goranova-Marinova, Eirini Katodritou, Mamta Garg, Michael G. Kauffman, Paul G. Richardson, Lingling Li, Monica Galli, Sosana Delimpasi, Sebastian Grosicki, Jelena Bila, Galina Salogub, Dinesh Kumar Sinha, Holger W. Auner, Larry D. Anderson, Sybiryna Korenkova, Don A. Stevens, Melina Arazy, Reuben Benjamin, Supratik Basu, Jacqueline Jeha, Moshe Yair Levy, Artur Jurczyszyn, Nizar J. Bahlis, Jean Richard Saint-Martin, Jatin P. Shah, Hang Quach, Anna M. Liberati, Tuphan Kanti Dolai, Iryrna Kriachok, Roman Hájek, Anita A. Joshi, Darrell White, Michele Cavo, Sundar Jagannath, Meletios A. Dimopoulos, Xavier Leleu, Hanna Oliynyk, Pawel Robak, Maryana Simonova, Ganna Usenko, Ludek Pour, Maria V. Mateos, Ivan Spicka, Moshe E. Gatt, Atanas Radinoff, Craig T. Wallington-Beddoe, Jeevan Kumar, Vishnuvardhan Peddagali, Halyna Pylypenko, Thierry Facon, Christopher P. Venner, Donna E. Reece, Sharon Shacham, Maria Gavriatopoulou, Yi Chai, Mercedes Gironella, Vadim A Doronin, P. Moreau
Publikováno v:
Lancet (London, England). 396(10262)
Summary Background Selinexor combined with dexamethasone has shown activity in patients with heavily pre-treated multiple myeloma. In a phase 1b/2 study, the combination of oral selinexor with bortezomib (a proteasome inhibitor) and dexamethasone ind
Autor:
Wayne B. Batchelor, Stephen G. Ellis, Gregg W. Stone, Anita A. Joshi, Paul L. Underwood, John A. Ormiston, Hong Wang
Publikováno v:
Journal of Interventional Cardiology. 26:49-57
Objectives To assess the influence of race on long-term outcomes following percutaneous coronary intervention (PCI) with paclitaxel-eluting stents (PES). Background Data on the influence of race on long-term outcomes following PCI with drug-eluting s
Autor:
Anita A. Joshi, Seif El-Jack, Raúl Moreno, Jean Fajadet, Ian T Meredith, Keith D. Dawkins, Stefan Verheye, Simon J Walsh, Christophe Dubois, Dominic J. Allocco, Keith G. Oldroyd, Olivier Varenne, Didier Carrié, Joseph Dens
Publikováno v:
Journal of the American College of Cardiology. 59(15):1362-1370
Objectives This study sought to compare the safety and efficacy of 2 dose formulations of SYNERGY, a novel bioabsorbable polymer everolimus-eluting stent (EES) (Boston Scientific Corp., Natick, Massachusetts) compared with the durable polymer PROMUS
Autor:
Stephen G. Ellis, Ghada W. Mikhail, Donald S. Baim, Anita A. Joshi, Antonio Colombo, David A. Cox, Mark Turco, John M. Lasala, John A. Ormiston, Robert Gerber, Gregg W. Stone
Publikováno v:
JACC: Cardiovascular Interventions. 3(12):1250-1259
Objectives We conducted the “TAXUS Woman” analysis to assess the influence of sex on long-term outcomes after percutaneous coronary intervention using paclitaxel-eluting stents (PES) in a broad spectrum of patients. Background Previous studies in
Autor:
Ian T, Meredith, Stefan, Verheye, Christophe L, Dubois, Joseph, Dens, Jean, Fajadet, Didier, Carrié, Simon, Walsh, Keith G, Oldroyd, Olivier, Varenne, Seif, El-Jack, Raul, Moreno, Anita A, Joshi, Dominic J, Allocco, Keith D, Dawkins
Publikováno v:
Journal of the American College of Cardiology. 59(15)
This study sought to compare the safety and efficacy of 2 dose formulations of SYNERGY, a novel bioabsorbable polymer everolimus-eluting stent (EES) (Boston Scientific Corp., Natick, Massachusetts) compared with the durable polymer PROMUS Element EES
Autor:
Ghada W, Mikhail, Robert T, Gerber, David A, Cox, Stephen G, Ellis, John M, Lasala, John A, Ormiston, Gregg W, Stone, Mark A, Turco, Anita A, Joshi, Donald S, Baim, Antonio, Colombo
Publikováno v:
JACC. Cardiovascular interventions. 3(12)
We conducted the "TAXUS Woman" analysis to assess the influence of sex on long-term outcomes after percutaneous coronary intervention using paclitaxel-eluting stents (PES) in a broad spectrum of patients.Previous studies indicate that the sex gap sug
Autor:
Daniel E. Forman, Stephen G. Ellis, John A. Ormiston, Jeanne Y. Wei, Mark Turco, John M. Lasala, Anita A. Joshi, Gregg W. Stone, Donald S. Baim, Keith D. Dawkins, David A. Cox
Publikováno v:
Circulation. Cardiovascular interventions. 2(3)
Background— Although drug-eluting stents have become a mainstay of percutaneous coronary intervention, information about drug-eluting stents outcomes in elderly patients is limited. Data from the paclitaxel-eluting stent (PES) trials and registries
Autor:
Melisenda J. McDonald, Kazuhiko Adachi, Yi Yang, Adrianna Morris, Gayathri Vasudevan, Anita A. Joshi
Publikováno v:
Biochemical and biophysical research communications. 289(1)
The rates of alpha/beta monomer combination of four beta(A) variants (beta 112C --S, beta 112C --D, beta 112C --T, and beta 112C --V) in the presence and absence of beta 16G --D (beta(J)) were measured in an attempt to assess the consequences of amin
Publikováno v:
Medical Devices (Auckland, N.Z.)
Video abstract Video
Everolimus-eluting stents (EES) have become the most commonly implanted coronary stents worldwide. This review describes and analyzes the clinical data supporting the use of EES, focusing primarily on published, randomized,
Everolimus-eluting stents (EES) have become the most commonly implanted coronary stents worldwide. This review describes and analyzes the clinical data supporting the use of EES, focusing primarily on published, randomized,
Autor:
Joshi A; Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA., Su LJ; Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA., Orloff MS; Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.; Center for the Study of Tobacco, Department Health Behavior and Health Education, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Publikováno v:
Epidemiologia (Basel, Switzerland) [Epidemiologia (Basel)] 2023 Dec 05; Vol. 4 (4), pp. 525-537. Date of Electronic Publication: 2023 Dec 05.